Abstract
Alternative splicing of human tyrosine hydroxylase (hTH) transcripts appears to occur mainly in the N-terminal domain, giving rise to at least eight different isoforms. We recently reported the existence of hTH transcript variants resulting from splicing of exons 8 and 9, within a region previously thought to be constant. The mRNA distribution of these novel hTH isoforms in neuroblastic tumours and in foetal adrenal glands was analysed by conventional and real-time RT-PCR. The presence of the target protein was determined by Western blotting, immunoprecipitation and protein analysis. Transcripts lacking exons 8 and 9 were widely distributed in the tissues analysed. Characterisation of full-length mRNA revealed that splicing of exons 8 and 9 was always associated with splicing of exons 2 (hTH-Δ2,8,9) or 1b and 2 (hTH-Δ1b,2,8,9). In addition, one variant detected on Western blots in several tumours fits the predicted size (58 kDa) of the isoforms lacking exons 8 and 9. In conclusion, the two novel isoforms reported here (hTH-Δ2,8,9 and hTH-Δ1b,2,8,9) represent the first full-length isoforms with alternative splicing in the hTH C-terminal domain. These results demonstrate for the first time the existence of hTH isoforms Δ2,8,9 and Δ1b,2,8,9. Their general distribution in neuroblastoma and adrenal glands and translation into protein suggest a significant functional role for these novel hTH isoforms, which merit further study.
References
Alterio, J., Ravassard, P., Haavik, J., Le Caer, J.P., Biguet, N.F., Waksman, G., and Mallet, J. (1998). Human tyrosine hydroxylase isoforms. Inhibition by excess tetrahydropterin and unusual behavior of isoform 3 after cAMP-dependent protein kinase phosphorylation. J. Biol. Chem.273, 10196–10201.10.1074/jbc.273.17.10196Search in Google Scholar
Brinkman, B.M. (2004). Splice variants as cancer biomarkers. Clin. Biochem.37, 584–594.10.1016/j.clinbiochem.2004.05.015Search in Google Scholar
Dumas, S., Le Hir, H., Bodeau-Pean, S., Hirsch, E., Thermes, C., and Mallet, J. (1996). New species of human tyrosine hydroxylase mRNA are produced in variable amounts in adrenal medulla and are overexpressed in progressive supranuclear palsy. J. Neurochem.67, 19–25.10.1046/j.1471-4159.1996.67010019.xSearch in Google Scholar
Goodwill, K.E., Sabatier, C., Marks, C., Raag, R., Fitzpatrick, P.F., and Stevens, R.C. (1997). Crystal structure of tyrosine hydroxylase at 2.3 Å and its implications for inherited neurodegenerative diseases. Nat. Struct. Biol.4, 578–585.Search in Google Scholar
Grima, B., Lamouroux, A., Boni, C., Julien, J.F., Javoy-Agid, F., and Mallet, J. (1987). A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature326, 707–711.10.1038/326707a0Search in Google Scholar
Haycock, J.W. (1990). Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem.265, 11682–11691.10.1016/S0021-9258(19)38451-0Search in Google Scholar
Haycock, J.W. (1993). Multiple forms of tyrosine hydroxylase in human neuroblastoma cells: quantitation with isoform-specific antibodies. J. Neurochem.60, 493–502.10.1111/j.1471-4159.1993.tb03177.xSearch in Google Scholar
Kaneda, N., Kobayashi, K., Ichinose, H., Kishi, F., Nakazawa, A., Kurosawa, Y., Fujita, K., and Nagatsu, T. (1987). Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem. Biophys. Res. Commun.146, 971–975.10.1016/0006-291X(87)90742-XSearch in Google Scholar
Kelner, K.L., Levine, R.A., Morita, K., and Pollard, H.B. (1985). A comparison of trihydroxyindole and HPLC/electrochemical methods for catecholamine measurement in adrenal chromaffin cells. Neurochem. Int.7, 373–378.10.1016/0197-0186(85)90128-7Search in Google Scholar
Kobayashi, K., Kaneda, N., Ichinose, H., Kishi, F., Nakazawa, A., Kurosawa, Y., Fujita, K., and Nagatsu, T. (1988). Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J. Biochem. (Tokyo)103, 907–912.10.1093/oxfordjournals.jbchem.a122386Search in Google Scholar PubMed
Livak, K.J. and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods25, 402–408.10.1006/meth.2001.1262Search in Google Scholar PubMed
Morita, K., Teraoka, K., and Oka, M. (1987). Interaction of cytoplasmic tyrosine hydroxylase with chromaffin granule. J. Biol. Chem.262, 5654–5658.10.1016/S0021-9258(18)45624-4Search in Google Scholar
Nagatsu, T., Levitt, M., Udenfriend, S. (1964). Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem.239, 2910–2917.10.1016/S0021-9258(18)93832-9Search in Google Scholar
Ohye, T., Ichinose, H., Yoshizawa, T., Kanazawa, I., and Nagatsu, T. (2001). A new splicing variant for human tyrosine hydroxylase in the adrenal medulla. Neurosci. Lett.312, 157–160.10.1016/S0304-3940(01)02210-8Search in Google Scholar
O'Malley, K.L., Anhalt, M.J., Martin, B.M., Kelsoe, J.R., Winfield, S.L., and Ginns, E.I. (1987). Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry26, 6910–6914.10.1021/bi00396a007Search in Google Scholar
Parareda, A., Villaescusa, J.C., Sanchez de Toledo, J., and Gallego, S. (2003). New splicing variants for human tyrosine hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma. Neurosci. Lett.336, 29–32.10.1016/S0304-3940(02)01220-XSearch in Google Scholar
Relogio, A., Ben-Dov, C., Baum, M., Ruggiu, M., Gemund, C., Benes, V., Darnell, R.B., and Valcarcel, J. (2005). Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J. Biol. Chem.280, 4779–4784.10.1074/jbc.M411976200Search in Google Scholar PubMed
©2007 by Walter de Gruyter Berlin New York
